Antonio Costanzo

43PUBLICATIONS
205CO-AUTHORS
AllergyEpigenetics (incl. genome methylation and epigenomics)Cancer therapy (excl. chemotherapy and radiation therapy)Major global burdens of diseaseAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (43)

|Jul 25, 2026
JAK Inhibitor Safety in Atopic Dermatitis and Alopecia Areata: A 4.5-Year Real-World Retrospective Cohort Study.

|Jul 22, 2026
Treatment Outcomes of Lebrikizumab after Switching from Dupilumab in Moderate-to-Severe Atopic Dermatitis involving the Head and Neck Area.

|Jul 09, 2026
ADAR1 loss-of-function variants altering RNA editing define a new interferon-dependent psoriasis subtype.

|Jul 03, 2026
Comparative Effectiveness and Safety of Baricitinib and Ritlecitinib in Severe Alopecia Areata: A Real-World Monocentric Retrospective Study.

|May 26, 2026
The Importance of Achieving High Treatment Targets in Atopic Dermatitis: A Narrative Review.

|Apr 24, 2026
Tildrakizumab Improves Disease Severity and Patient-Reported Outcomes in Moderate-to-Severe Chronic Plaque Psoriasis: A Prospective Real-World Study.

Pageof 8

Frequent Collaborators

22 joint publications

Luigi Gargiulo

16 joint publications

Luciano Ibba

12 joint publications

Mario Valenti

9 joint publications

Alessandra Narcisi